Insider Trading Arrangements	3 Months Ended
	Jun. 30, 2024 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	On June 30, 2024, each of Shannon Morris, M.D., Ph.D., our Chief Medical Officer, and Ebun Garner, J.D., our General Counsel, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 80,000 and 200,000 shares of our common stock until March 31, 2026 and June 30, 2026, respectively.
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Rule 10b5-1 Arrangement Modified	false
Non-Rule 10b5-1 Arrangement Modified	false
Shannon Morris [Member]
Trading Arrangements, by Individual
Name	Shannon Morris
Title	M.D., Ph.D., our Chief Medical Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 30, 2024
Expiration Date	March 31, 2026
Arrangement Duration	640 days
Aggregate Available	80,000
Ebun Garner [Member]
Trading Arrangements, by Individual
Name	Ebun Garner
Title	J.D., our General Counsel
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 30, 2024
Expiration Date	June 30, 2026
Arrangement Duration	731 days
Aggregate Available	200,000